147 related articles for article (PubMed ID: 32605368)
1. Manno-
Armstrong Z; Kuo CL; Lahav D; Liu B; Johnson R; Beenakker TJM; de Boer C; Wong CS; van Rijssel ER; Debets MF; Florea BI; Hissink C; Boot RG; Geurink PP; Ovaa H; van der Stelt M; van der Marel GM; Codée JDC; Aerts JMFG; Wu L; Overkleeft HS; Davies GJ
J Am Chem Soc; 2020 Jul; 142(30):13021-13029. PubMed ID: 32605368
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of Golgi alpha-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen.
Kuntz DA; Tarling CA; Withers SG; Rose DR
Biochemistry; 2008 Sep; 47(38):10058-68. PubMed ID: 18759458
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography.
Englebienne P; Fiaux H; Kuntz DA; Corbeil CR; Gerber-Lemaire S; Rose DR; Moitessier N
Proteins; 2007 Oct; 69(1):160-76. PubMed ID: 17557336
[TBL] [Abstract][Full Text] [Related]
4. Structural investigation of the binding of 5-substituted swainsonine analogues to Golgi alpha-mannosidase II.
Kuntz DA; Nakayama S; Shea K; Hori H; Uto Y; Nagasawa H; Rose DR
Chembiochem; 2010 Mar; 11(5):673-80. PubMed ID: 20209559
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of inhibition of Golgi alpha-mannosidase II by mannostatin A.
Kuntz DA; Zhong W; Guo J; Rose DR; Boons GJ
Chembiochem; 2009 Jan; 10(2):268-77. PubMed ID: 19101978
[TBL] [Abstract][Full Text] [Related]
6. Structure, mechanism and inhibition of Golgi α-mannosidase II.
Rose DR
Curr Opin Struct Biol; 2012 Oct; 22(5):558-62. PubMed ID: 22819743
[TBL] [Abstract][Full Text] [Related]
7. 1,4-Dideoxy-1,4-imino-D- and L-lyxitol-based inhibitors bind to Golgi α-mannosidase II in different protonation forms.
Kóňa J; Šesták S; Wilson IBH; Poláková M
Org Biomol Chem; 2022 Nov; 20(45):8932-8943. PubMed ID: 36322142
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of broad-specificity activity-based probes for
McGregor NGS; Kuo CL; Beenakker TJM; Wong CS; Offen WA; Armstrong Z; Florea BI; Codée JDC; Overkleeft HS; Aerts JMFG; Davies GJ
Org Biomol Chem; 2022 Jan; 20(4):877-886. PubMed ID: 35015006
[No Abstract] [Full Text] [Related]
9. N-Benzyl Substitution of Polyhydroxypyrrolidines: The Way to Selective Inhibitors of Golgi α-Mannosidase II.
Šesták S; Bella M; Klunda T; Gurská S; Džubák P; Wöls F; Wilson IBH; Sladek V; Hajdúch M; Poláková M; Kóňa J
ChemMedChem; 2018 Feb; 13(4):373-383. PubMed ID: 29323461
[TBL] [Abstract][Full Text] [Related]
10. Golgi alpha-mannosidase II cleaves two sugars sequentially in the same catalytic site.
Shah N; Kuntz DA; Rose DR
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9570-5. PubMed ID: 18599462
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of the glycosylation step catalyzed by Golgi alpha-mannosidase II: a QM/MM metadynamics investigation.
Petersen L; Ardèvol A; Rovira C; Reilly PJ
J Am Chem Soc; 2010 Jun; 132(24):8291-300. PubMed ID: 20504027
[TBL] [Abstract][Full Text] [Related]
12. Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant.
Zhong W; Kuntz DA; Ember B; Singh H; Moremen KW; Rose DR; Boons GJ
J Am Chem Soc; 2008 Jul; 130(28):8975-83. PubMed ID: 18558690
[TBL] [Abstract][Full Text] [Related]
13. Golgi α-mannosidase: opposing structures of
Drogalin A; Monteiro LS; Alves MJ; Castro TG
J Biomol Struct Dyn; 2024 Mar; 42(5):2714-2725. PubMed ID: 37158092
[TBL] [Abstract][Full Text] [Related]
14. Human lysosomal alpha-mannosidases exhibit different inhibition and metal binding properties.
Venkatesan M; Kuntz DA; Rose DR
Protein Sci; 2009 Nov; 18(11):2242-51. PubMed ID: 19722277
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, enzymatic activity, and X-ray crystallography of an unusual class of amino acids.
Chen W; Kuntz DA; Hamlet T; Sim L; Rose DR; Mario Pinto B
Bioorg Med Chem; 2006 Dec; 14(24):8332-40. PubMed ID: 17010621
[TBL] [Abstract][Full Text] [Related]
16. Using DFT methodology for more reliable predictive models: Design of inhibitors of Golgi α-Mannosidase II.
Bobovská A; Tvaroška I; Kóňa J
J Mol Graph Model; 2016 May; 66():47-57. PubMed ID: 27035259
[TBL] [Abstract][Full Text] [Related]
17. Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms.
Shah N; Kuntz DA; Rose DR
Biochemistry; 2003 Dec; 42(47):13812-6. PubMed ID: 14636047
[TBL] [Abstract][Full Text] [Related]
18. Kinetic studies on cyclophellitol analogues--mechanism-based inactivators.
Tai VW; Fung PH; Wong YS; Shing TK
Biochem Biophys Res Commun; 1995 Aug; 213(1):175-80. PubMed ID: 7639733
[TBL] [Abstract][Full Text] [Related]
19. Alpha-mannosidases involved in N-glycan processing show cell specificity and distinct subcompartmentalization within the Golgi apparatus of cells in the testis and epididymis.
Igdoura SA; Herscovics A; Lal A; Moremen KW; Morales CR; Hermo L
Eur J Cell Biol; 1999 Jul; 78(7):441-52. PubMed ID: 10472797
[TBL] [Abstract][Full Text] [Related]
20. Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals.
Moremen KW
Biochim Biophys Acta; 2002 Dec; 1573(3):225-35. PubMed ID: 12417404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
